Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination.

Saved in:

Bibliographic Details
Title:	Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination.
Authors:	Phares TW; Thunder Biotech, Provo, UT, United States., Huang J; The Aaron Diamond AIDS Research Center, New York, NY, United States.; Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States., Kotraiah V; Leidos Life Sciences, Leidos Inc., Frederick, MD, United States., Hauser MJ; GeoVax Inc., Atlanta, GA, United States., Domi A; GeoVax Inc., Atlanta, GA, United States., Oruganti S; GeoVax Inc., Atlanta, GA, United States., Browne CD; Thermo Fisher Scientific, San Diego, CA, United States., Buontempo P; The MITRE Corporation, McLean, VA, United States., Mansour M; MM Scientific Consultants Inc., Halifax, NS, Canada., Pannucci J; The MITRE Corporation, McLean, VA, United States., Tsuji M; The Aaron Diamond AIDS Research Center, New York, NY, United States.; Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States., Gutierrez GM; Hibiscus Biotechnology, LLC, Rockville, MD, United States.
Source:	Frontiers in pharmacology [Front Pharmacol] 2022 Dec 13; Vol. 13, pp. 1029636. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2022.1029636